Kennedy Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Kennedy Capital Management's RYTM Position: Q3 2026 in Review
Kennedy Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 2.8% in Q3 2026, buying an estimated $570K and bringing the position to 198,557 shares worth $18.9M. The position accounts for 0.36% of the portfolio, ranked #81.
Kennedy Capital Management first reported a position in RYTM in Q2 2024 and has held it in 8 quarters since. The position peaked at $21.5M in Q2 2026. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Kennedy Capital Management held 198,557 shares of Rhythm Pharmaceuticals worth $18.9M as of Q3 2026.
- Kennedy Capital Management bought 5,342 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $570K.
- Rhythm Pharmaceuticals made up 0.36% of Kennedy Capital Management's portfolio in Q3 2026, its #81 holding.
- Kennedy Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
- Kennedy Capital Management's Rhythm Pharmaceuticals position peaked at $21.5M in Q2 2026.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.